Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily vs. Alternate Day Icodextrin in Peritoneal Dialysis
NCT05943470Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2023
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
01
Overview
A Phase 4 trial of icodextrin in end stage renal disease (ESRD), sponsored by Renji Hospital. Status: unknown.
02
Drugs
icodextrin
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT05943470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05943470.